Sign In
Buy LLY
$1,185.71
-6.23 (-0.523%)
At Close: Aug 07, 2026
Weight loss drugs Wegovy and Zepbound to debut in pill form
10:51am, Friday, 17'th Nov 2023
Popular weight loss drugs Wegovy and Zepbound will soon be available in pill form. Pharmaceutical giants Novo Nordisk (NYSE:NVO) and Eli Lilly and Co (NYSE:LLY) are actively promoting pill versions of
Eli Lilly plans $2.5B site in Germany to expand injectable manufacturing capacity
09:21am, Friday, 17'th Nov 2023
Eli Lilly and Co (NYSE:LLY) has announced plans for a new $2.5 billion high-tech manufacturing site in Germany to expand its global parenteral (injectable) product and device manufacturing network. Th
13F Rundown: Tepper, Buffett, Druckenmiller
09:01am, Friday, 17'th Nov 2023
Stock Strategist Andrew Rocco divulges valuable insights from the world's best and brightest investors.
Eli Lilly to build $2.5 billion plant in Germany to support rising demand for obesity, diabetes drugs
08:12am, Friday, 17'th Nov 2023
Shares of Eli Lilly & Co. LLY, +0.04% rose 0.67% in premarket trading Friday after drug giant announced plans to spend $2.5 billion to build a new manufacturing facility in Germany. The new facility i
Retail investors crowd into Eli Lilly after weight-loss drug approval
08:03am, Friday, 17'th Nov 2023
Retail flows into Eli Lilly spiked to a more than two-year high in November, as small investors rushed to buy the stock after the U.S. pharma major received a highly anticipated approval for its weigh
Weight loss drugs and stocks: Breaking down the GLP1 market for investors
11:42am, Thursday, 16'th Nov 2023
Weight loss drugs are at the forefront of demand in the pharmaceutical sector as major drug manufacturers Novo Nordisk (NVO) and Lilly (LLY) undergoing clinical trials for new GLP-1 drugs. And, one an
Eli Lilly plans new 2 billion euro German plant -source
06:26am, Thursday, 16'th Nov 2023
U.S. pharmaceuticals company Eli Lilly plans to build a new plant in western Germany, sources close to the matter told Reuters, with one putting the investment at 2 bln euros
Eli Lilly: Perfectly Priced Healthcare Giant
06:19am, Thursday, 16'th Nov 2023
Eli Lily has the highest market capitalization of any Healthcare company, but its low revenue does not justify its lofty valuation at first glance. However, the company's average 5-year forward growth
Eli Lilly plans to invest 2 bln euros in new German plant -source
05:17am, Thursday, 16'th Nov 2023
U.S. pharma company Eli Lilly plans to invest 2 billion euros ($2.17 billion) in a new plant in Alzey, western Germany, a source close to the negotiations told Reuters on Thursday.
Why Eli Lilly Stock Flopped While the Market Popped Today
06:00pm, Wednesday, 15'th Nov 2023
A media report stated that the pharmaceutical giant intends to build a new factory in Germany. It will apparently fund the project entirely on its own.
Lilly plans single-digit billion dollar new German plant - sources
02:04pm, Wednesday, 15'th Nov 2023
U.S. pharma giant Eli Lilly plans an investment in the single-digit billion dollar range in a new plant in western Germany, people familiar with the matter told Reuters after the company called a pres
Investors increase holdings of weight-loss drug makers' shares in Q3 -filings
06:46pm, Tuesday, 14'th Nov 2023
Some big investors showed increased appetite for weight-loss drug makers in the third quarter, piling in to shares of Eli Lilly and Novo Nordisk amid growing demand for their product, securities filin
Why It's Time to Sell These 3 Hot Stocks
04:06pm, Tuesday, 14'th Nov 2023
Stock gains are great, but they don't necessarily continue forever. Today's fast rising investment can be tomorrow's disappointment.
Employer coverage of GLP-1 drugs for weight loss lags far behind diabetes coverage, survey finds
03:34pm, Tuesday, 14'th Nov 2023
For workers in employer-sponsored health plans, coverage of Wegovy and other GLP-1 medications for weight loss is lagging far behind coverage of that class of drugs for diabetes, a new survey shows.
Eli Lilly Is Planning to Dominate the Weight Loss Market and Make Billions. Here's Why It'll Keep Winning
07:45am, Tuesday, 14'th Nov 2023
Eli Lilly's weight-loss medicine Zepbound was just approved for sale by regulators. It's buying businesses and making investments to drive further growth.
